Zobrazeno 1 - 10
of 179
pro vyhledávání: '"Alberto, Fabbri"'
Autor:
Emanuele Cencini, Natale Calomino, Marta Franceschini, Andreea Dragomir, Sara Fredducci, Beatrice Esposito Vangone, Giulia Lucco Navei, Alberto Fabbri, Monica Bocchia
Publikováno v:
Hematology Reports, Vol 16, Iss 1, Pp 50-62 (2024)
Mantle cell lymphoma (MCL) prognosis has significantly improved in recent years; however, the possible survival benefit of new treatment options should be evaluated outside of clinical trials. We investigated 73 consecutive MCL patients managed from
Externí odkaz:
https://doaj.org/article/53149ed5c09544d2a87dd9973ae1b497
Autor:
Martina D’Onghia, Alessandra Cartocci, Laura Calabrese, Daniele Maio, Azzurra Sirchio, Maria Erasti, Linda Tognetti, Pietro Rubegni, Monica Bocchia, Emanuele Cencini, Alberto Fabbri, Elisa Cinotti
Publikováno v:
Current Oncology, Vol 30, Iss 11, Pp 9813-9823 (2023)
Data on primary cutaneous lymphomas (PCLs) patients in the Italian population are limited, and, despite the existence of several treatment options, the management of those patients remains challenging. Our study aimed to investigate the clinical and
Externí odkaz:
https://doaj.org/article/e77ca9a46804480e9bc25f2e421bc151
Autor:
Emanuele Cencini, Anna Sicuranza, Sara Ciofini, Alberto Fabbri, Monica Bocchia, Alessandro Gozzetti
Publikováno v:
Current Oncology, Vol 30, Iss 7, Pp 6111-6133 (2023)
Multiple myeloma (MM) is characterized by multiple relapse and, despite the introduction of novel therapies, the disease becomes ultimately drug-resistant. The tumor microenvironment (TME) within the bone marrow niche includes dendritic cells, T-cyto
Externí odkaz:
https://doaj.org/article/2252aa642bba456b8eb95100ddff8b8e
Autor:
Claudia Bartolini, Giuseppe Roberto, Anna Girardi, Valentino Moscatelli, Andrea Spini, Alessandro Barchielli, Monica Bocchia, Alberto Fabbri, Sandra Donnini, Marina Ziche, Maria Cristina Monti, Rosa Gini
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionItalian administrative healthcare databases are frequently used for studies on real-world drug utilization. However, there is currently a lack of evidence on the accuracy of administrative data in describing the use of infusive antineopla
Externí odkaz:
https://doaj.org/article/65cf1928949b46bdbc224853dba25098
Autor:
Manuel Gotti, Roberta Sciarra, Alessandro Pulsoni, Francesco Merli, Stefano Luminari, Caterina Zerbi, Livio Trentin, Alessandro Re, Chiara Rusconi, Simonetta Viviani, Andrea Rossi, Federica Cocito, Barbara Botto, Erika Meli, Antonello Pinto, Irene Dogliotti, Guido Gini, Benedetta Puccini, Francesca Ricci, Luca Nassi, Alberto Fabbri, Anna Marina Liberati, Michele Merli, Andrea Riccardo Filippi, Maurizio Bonfichi, Valentina Zoboli, Germana Tartaglia, Giorgia Annechini, Gianna Maria D’Elia, Ilaria Del Giudice, Isabel Alvarez, Andrea Visentin, Stefano Pravato, Daniela Dalceggio, Chiara Pagani, Silvia Ferrari, Caterina Cristinelli, Tanja Lazic, Virginia Valeria Ferretti, Umberto Ricardi, Luca Arcaini
Publikováno v:
HemaSphere, Vol 7, Iss 4, p e837 (2023)
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare entity whose neoplastic cells retain a B-cell phenotype with expression of CD20. Radiotherapy is recommended for favorable stage IA disease while for other stages guidelines suggest th
Externí odkaz:
https://doaj.org/article/09f7bb15b7604be5994072aa44cd7825
Autor:
Lisa Argnani, Alessandro Broccoli, Cinzia Pellegrini, Alberto Fabbri, Benedetta Puccini, Riccardo Bruna, Maria Chiara Tisi, Francesco Masia, Leonardo Flenghi, Maria Elena Nizzoli, Maurizio Musso, Marilena Salerno, Potito Rosario Scalzulli, Daniela Dessi’, Isacco Ferrarini, Elsa Pennese, Elisa Lucchini, Francesca Gaia Rossi, Carla Minoia, Filippo Gherlinzoni, Pellegrino Musto, Caterina Patti, Vittorio Stefoni, Pier Luigi Zinzani
Publikováno v:
HemaSphere, Vol 6, Iss 12, p e798 (2022)
After FDA and EMA approval of the regimen containing polatuzumab vedotin plus rituximab and bendamustine (PolaBR), eligible relapsed/refractory diffuse large B-cell lymphoma (DLBCL) patients in Italy were granted early access through a Named Patient
Externí odkaz:
https://doaj.org/article/1cc1af983bd1486091a4adbd8c7747a9
Autor:
Alessandra Tucci, Francesco Merli, Alberto Fabbri, Luigi Marcheselli, Chiara Pagani, Benedetta Puccini, Dario Marino, Manuela Zanni, Elsa Pennese, Leonardo Flenghi, Annalisa Arcari, Barbara Botto, Melania Celli, Caterina Mammi, Alessandro Re, Giulia Campostrini, Agostino Tafuri, Vittorio R. Zilioli, Emanuele Cencini, Roberto Sartori, Chiara Bottelli, Michele Merli, Luigi Petrucci, Guido Gini, Monica Balzarotti, Federica Cavallo, Gerardo Musuraca, Stefano Luminari, Giuseppe Rossi, Michele Spina
Publikováno v:
Haematologica, Vol 108, Iss 4 (2022)
Octogenarian patients with diffuse large B-cell lymphoma are managed mainly with palliation, but recent improvement in their overall condition makes potentially curative treatment a possibility. Studies have shown that half of selected octogenarians
Externí odkaz:
https://doaj.org/article/12dfe59dc2684c01b9933e3cf71feb85
Autor:
Alessandro Gozzetti, Francesca Bacchiarri, Vincenzo Sammartano, Marzia Defina, Anna Sicuranza, Bianca Mecacci, Elisabetta Zappone, Emanuele Cencini, Alberto Fabbri, Donatella Raspadori, Monica Bocchia
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Multiple myeloma survival has significantly improved in recent years, due to novel agents that are available for treatment. The anti-CD38 monoclonal antibody Daratumumab is particularly efficient for patients with relapse/refractory disease, and many
Externí odkaz:
https://doaj.org/article/574bbad432b34732bc27d83887f93ae8
Autor:
Emanuele Cencini, Ilaria Romano, Francesco Ghio, Chiara Camerini, Ilaria Bertaggia, Roberta Giachetti, Lara Mannelli, Maria Teresa Pirrotta, Giulia Lucco Navei, Manuel Ciceri, Giulia Cervetti, Emanuela Sant’Antonio, Federico Simonetti, Silvia Birtolo, Benedetta Puccini, Monica Bocchia, Alberto Fabbri
Publikováno v:
Annals of Hematology. 102:841-849
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51be50d8ca8da1c14f72d7f465bc7c6a
https://doi.org/10.1007/s00277-023-05113-9
https://doi.org/10.1007/s00277-023-05113-9
Autor:
Annalisa Arcari, Valentina Tabanelli, Francesco Merli, Luigi Marcheselli, Michele Merli, Monica Balzarotti, Vittorio Ruggero Zilioli, Alberto Fabbri, Federica Cavallo, Gloria Margiotta Casaluci, Alessandra Tucci, Benedetta Puccini, Elsa Pennese, Alice Di Rocco, Manuela Zanni, Leonardo Flenghi, Guido Gini, Roberto Sartori, Annalisa Chiappella, Sara Veronica Usai, Monica Tani, Dario Marino, Luca Arcaini, Daniele Vallisa, Michele Spina
Publikováno v:
British Journal of Haematology. 201:653-662
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ea26569402dfcbba630833fe86c83f9
https://doi.org/10.1111/bjh.18678
https://doi.org/10.1111/bjh.18678